ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NAN Nanoscience

4.375
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Nanoscience LSE:NAN London Ordinary Share KYG6390E1070 ORD 0.25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4.375 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Nanoscience Share Discussion Threads

Showing 601 to 623 of 775 messages
Chat Pages: 31  30  29  28  27  26  25  24  23  22  21  20  Older
DateSubjectAuthorDiscuss
15/4/2008
07:40
It will be interesting to see the credentials of the new board member,I hope its someone from the semiconductor/med.devices/biotech industries and I guess if that person was also American you could assume the NASDAQ listing (of Toumaz) is a certainty.Either way its a cert.in my opinion,when the U.S. market knows the calibre of the Toumaz partners they'll buy into it bigtime.
spekky
14/4/2008
21:32
Once adopted, it wa always going to be the case that controlling scale and growth would be the key management challenges. If they get that right, well, name your price.
the drewster
14/4/2008
15:55
I wonder if Cambridge County Council is the authority which has signed up to MyAmego.View the CCC video to see and hear how much councils are doing to enable care at home.Thats an item from last years event so perhaps theres a chance of MyAmego getting some video coverage at this years (end of April).Come on you Sentinel PR guys/gals,start plugging the idea with Naidex TV.It was interesting to read Guys comments that no part of Sentinel is up for grabs anytime soon,must have high expectations of it.

"We believe the opportunity to develop this business is substantial, both as an outlet for Toumaz product and forSentinel's own technology in other geographies. There is no intention of selling any part of the business and, in fact, we remain open to further investment aimed at the expansion of specific commercial opportunities."

spekky
11/4/2008
09:41
spekky - thanks - I had read that, but your memory's obviously better than mine - not hard these days, lol. I'll read it again this evening.
supernumerary
11/4/2008
09:34
Agreed.
And although this is currently a European initiative the outcome will have worldwide relevance and further enhance the Toumaz reputation (and royalties).

spekky
11/4/2008
09:21
This is also my biggest holding, have been here since it floated and i still beleive this has the potential to be my best investment yet, a ten bagger from here.
the shuffle man
11/4/2008
09:10
Found it,its to do with a "silicon pancreas chip" which adds "intelligence" to an implanted insulin pump.



PAGES 35 to 37 if your interested.

spekky
11/4/2008
09:06
This is my biggest holding of all, I have great hopes for the SP, the company have some great joint ventures and the technology is fast moving.

We should not be subjected to great swings in the price as the stock seems to be under the radar of the traders.

a2584728
11/4/2008
08:50
I think those who are "recurrently hospitalised" will need to have an implanted insulin delivery system which is then monitored non intrusively after the initial operation.I'm sure Chris Toumazou described this in his speech to the Royal Society last year (I seem to recalL posting a link to the PDF)
spekky
11/4/2008
08:42
through the digital plaster powered by Sensium Technology
the shuffle man
11/4/2008
08:33
How do you check glucose levels non-intrusively?
supernumerary
11/4/2008
08:33
Happy to be wrong....doh!

Just shows what a proper RNS can do,as opposed to the usual inconspicuous nature of NANs releases thru' PRN or TFN.

spekky
11/4/2008
08:22
Yes it does.


Nanoscience Inc
11 April 2008

Nanoscience Inc.
('Nanoscience' or the 'Group')

Toumaz Technology As Part of Consortium That Wins €7.1 million European
Community Grant

Nanoscience, the specialist niche investor in emerging technologies with strong
commercial propositions for the healthcare and electronic sectors, is pleased to announce that its wholly-owned subsidiary Toumaz Technology Limited ('Toumaz'), is part of a major collaborative research project that has been awarded a €7.1 million grant to fund the development of a portable blood glucose predictor system for diabetes patients.

The Personal Glucose Predictive Diabetes Advisor ('DIAdvisorTM') system is a
unique personalised blood glucose prediction tool that allows patients at any
time to actively and accurately predict their short-term blood glucose outlook
by the analysis of data retrieved from glucose measurements, insulin delivery
data and specific patient parameters, which will be captured by non-intrusive
body-worn wireless monitors based on Toumaz's breakthrough SensiumTM platform.

The grant award, made under the Seventh Framework Programme (FP7) of the
European Community, will fund the four-year research and development project
into the DIAdvisorTM system. The large-scale project is being coordinated by
Novo Nordisk A/S, a world leader in diabetes care, and will be delivered by a
consortium of 13 medical, industrial and academic partners, including the
European Division of the International Diabetes Federation.

Toumaz's role in the project will be to implement the DIAdvisorTM hardware and
software platform, leverage the SensiumTM intelligent data acquisition platform
and networking infrastructure to enable multiple vital signs measurements from
non-intrusive body-worn monitors to be taken and merged with manually entered '
spot' measurements (such as food intake), providing the key data for the
creation of physiological mathematical modeling, control and prediction
algorithms. The resulting analysis and prediction information will then be able
to be wirelessly transmitted to a healthcare provider advisory service, with
recommended action and treatment advice presented to the patient via a handheld
mobile device such as a Personal Digital Assistant (PDA).

First stage data gathering and clinical trials are planned to start in August
2008, with initial data expected by the end of the year.

Dr Alison Burdett, Director of Technology for Toumaz commented:

'With DIAdvisorTM, we will be putting a sophisticated treatment advisor in the
hands of patients for the first time, empowering them in their own healthcare
management and significantly reducing the likelihood of serious complications
and recurrent hospitalisation due to poor glucose control. For healthcare
providers, DIAdvisorTM will have a significant positive impact on cost reduction for the treatment of diabetes.'

Guy Spelman CEO of Nanoscience commented:

'This is further good news from our investment in Toumaz and its development of
the SensiumTM platform. Recognition of the growing importance of the SensiumTM
platform in more sectors in the field of medicine provides further evidence of
its versatility and increasing acceptance across global leaders and government
bodies.'


- Ends -

papalpower
11/4/2008
08:17
Market seems to like the news :-)
the shuffle man
10/4/2008
17:46
The Shuffle Man
That had already been flagged up at the last results (see below) although there is more detail now.

"5. Key achievementsTwo strong commercial partners, establishing a clear routes to market- Major industry recognition and awards during 2007- Key commercial member, along with Novo Nordisk, of consortium awarded 7.6
million Euros under an EU Framework 7 Project "DiAdvisor" to develop new tools
for the treatment of diabetes"

Still,any publicity that might arise from this could be a shot in the arm for the share price Unfortunately the announcement has n't even made PR Newswire so dont expect the share price to move north just yet.

spekky
10/4/2008
16:50
Toumaz Technology and Consortium Partners Win Major EU Funding To Develop Personal Blood Glucose Predictor For Diabetes Patients

have a look on the web site

the shuffle man
20/3/2008
11:23
Correct, I have now :)
ianood
20/3/2008
09:47
ianood

I presume you haven't read the Final Results properly.

spekky
20/3/2008
09:13
Spekky, I think you are bang on with the new name, its a pity they won't / can't announce it formally.
ianood
20/3/2008
09:13
Sensium chips shipping in production volumes in July 2008.
the shuffle man
20/3/2008
07:15
consideration of a Nasdaq quote for Toumaz.??????

The Drewster - 6 Mar'08 - 21:31 - 370 of 395
If it is OMX/Nasdaq, then I would say again, it might be significant that they take a stake.

I think that counts as a nail on the head Drewster...........good call.

BTW...Just google "fortune 100" and look at the top twenty,my inkling was Medtronic and I could n't be more gloriously/massively incorrect (Med. dont make the 500 never mind top twenty).To put it in perspective,Microsoft and Intel are 49th and 62nd respectively.Cardinal are HUGE (and I dont know how I missed them)

spekky
19/3/2008
14:56
Same again today? and regular rollovers appearing.
spekky
19/3/2008
14:38
A good read & chuckle.
mindymaru
Chat Pages: 31  30  29  28  27  26  25  24  23  22  21  20  Older

Your Recent History

Delayed Upgrade Clock